Old Web
English
Sign In
Acemap
>
authorDetail
>
Pascal Charef
Pascal Charef
Novartis
Medicine
Secukinumab
Internal medicine
Pharmacokinetics
Placebo
6
Papers
18
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Investigation of the effect of the dual orexin receptor antagonist almorexant on ophthalmological, spermatogenic, and hormonal variables in healthy male subjects.
2021
Biomedicine & Pharmacotherapy
Jasper Dingemanse
Pascal Charef
Jed Black
Chris Gouws
Show All
Source
Cite
Save
Citations (0)
27519 Efficacy, pharmacokinetics, and tolerability of subcutaneous secukinumab injections with 2 mL prefilled syringes (300 mg) in adult subjects with moderate to severe plaque psoriasis
2021
Journal of The American Academy of Dermatology
Bardur Sigurgeirsson
Knut Schäkel
Chih-ho Hong
Isaak Effendy
Waldemar Placek
Phoebe Rich
Gerard Bruin
Pascal Charef
Rong Fu
Isabelle Hampele
Manmath Patekar
Show All
Source
Cite
Save
Citations (0)
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis.
2020
Chinese Medical Journal
Lin Cai
Jianzhong Zhang
Xu Yao
Jun Gu
Quanzhong Liu
Min Zheng
Shi-Fa Zhang
Jinhua Xu
Cheng-Xin Li
Hao Cheng
Qing Guo
Wei Li Pan
Shen-Qiu Li
Ruoyu Li
Zai-pei Guo
Zhi-qi Song
Shan-Shan Li
Xiu-Qin Dong
Linda Wang
Rong Fu
Pascaline Regnault
Pascal Charef
Rafal Mazur
Manmath Patekar
Show All
Source
Cite
Save
Citations (6)
Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomised, controlled trial.
2020
Journal of The European Academy of Dermatology and Venereology
C. Bodemer
A. Kaszuba
Külli Kingo
A Tsianakas
Akimichi Morita
E Rivas
P. Papanastasiou
D. Keefe
Manmath Patekar
Pascal Charef
L. Zhang
S. Cafoncelli
Charis Papavassilis
Show All
Source
Cite
Save
Citations (10)
1